Skip to main content
. 2016 Feb 20;54(4):361–369. doi: 10.2486/indhealth.2015-0170

Table 3. The aberrantly expressed miRNA profiles based on the observation samples.

miRNA* Stage I/observation Stage II/ observation
hsa-miR-500a-5p 4.82 4.50
hsa-miR-1301-3p 4.17 5.98
hsa-miR-24-1-5p 0.20 0.23
hsa-miR-3144-3p 0.15 0.19
hsa-miR-152-3p 0.14 0.24
hsa-miR-5571-5p 0.14 0.16
hsa-miR-450a-5p 0.13 0.21
hsa-miR-204-5p 0.11 0.17
hsa-miR-497-5p 0.09 0.21
hsa-miR-24-2-5p 0.08 0.23
hsa-miR-195-5p 0.08 0.24
hsa-miR-323a-3p 0.07 0.15
hsa-miR-34c-5p 0.07 0.24
hsa-miR-199a-3p 0.07 0.22
hsa-miR-203a 0.06 0.25
hsa-miR-181c-5p 0.05 0.17
hsa-miR-96-5p 0.05 0.24
hsa-miR-1 0.03 0.21
hsa-miR-182-5p 0.03 0.20
hsa-miR-34b-3p 0.02 0.25
hsa-miR-136-5p 0.02 0.15
hsa-miR-31-5p 0.01 0.06
hsa-miR-1267 0.15 0.07

*The listed miRNAs are abundantly expressed in both two groups.